Transcriptomics

Dataset Information

0

Expression data of human melanoma cell lines treated with siRNA targeting SR-BI or with the pharmacologic inhibitor BLT-1


ABSTRACT: Melanoma patients with high mRNA levels of the HDL receptor SR-BI (SCARB1) reveal poor survival outcome. The aim of the study was to evaluate the role of SR-BI in cancer progression. Therefore, SR-BI was targeted either by siRNA or by using the SR-BI specific lipid transfer inhibitor BLT-1. The SR-BI knockdown specifically revealed reduced protein glycosylation, STAT5 target gene expression and EMT pathway activation. Thus, SR-BI target genes reflect the metastatic phenotype in melanoma cells. We used the transcriptome analysis to compare SR-BI depletion to BLT-1 treatment (which specifically blocks SR-BI mediated lipid transfer) in human melanoma cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE96743 | GEO | 2018/01/02

SECONDARY ACCESSION(S): PRJNA379535

REPOSITORIES: GEO

Similar Datasets

2018-09-21 | GSE115091 | GEO
| PRJNA379535 | ENA
2017-11-01 | GSE101871 | GEO
2018-03-30 | GSE112119 | GEO
2013-04-05 | GSE44591 | GEO
2013-04-05 | E-GEOD-44591 | biostudies-arrayexpress
2013-09-01 | E-GEOD-49937 | biostudies-arrayexpress
2014-11-23 | E-GEOD-63263 | biostudies-arrayexpress
2014-11-23 | E-GEOD-63262 | biostudies-arrayexpress
2023-03-31 | GSE147834 | GEO